Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer, Vivascience to Develop Protein Fractionation Kits for PerkinElmer Biomarker System

NEW YORK, Aug. 3 (GenomeWeb News) - PerkinElmer has signed onto a collaboration with Vivascience to create fractionation kits for proteomics-based biomarker analysis, the companies said today.

 

Under the agreement, the companies will combine PerkinElmer's elution chemistries with Vivascience's membrane adsorber chromatography technology to create the kits. PerkinElmer said it will then market these biomarker screening reagent kits along with its biomarker screening instruments, which include its Multiprobe II liquid handling workstation and proTOF 2000 MALDI-TOF mass spectrometer. The parties did not disclose the financial terms of the agreement.

 

PerkinElmer also said that Predictive Diagnostics, which recently began using PerkinElmer's proTOF for its clinical proteomics program, will have early access to the PerkinElmer/Vivascience fractionation kits through the end of the year.

 

Vivascience, of Hannover, Germany, produces chromatography technology that is rigid, unlike traditional resins and beads, the companies said.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.